SCHEMBL23029076

SCHEMBL23029076

COC(=O)C1CN(c2ccc3c(c2)[Si](C)(C)c2cc(N4CCC4)ccc2C32OC(=O)c3ccc(C(=O)NCCOCCOCCCCCCCl)cc32)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.35
▸ NT5E P21589 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ F10 P00742 3/20 0.31
▸ PDE4A P27815 1/20 0.30
▸ PDE4B Q07343 1/20 0.30
▸ PDE4C Q08493 1/20 0.30
▸ PDE4D Q08499 1/20 0.30
▸ TLR2 O60603 2/20 0.30
▸ NOTUM Q6P988 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ MDM2 Q00987 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23029077 0.95 OPRM1 (0.34) OPRM1NT5EKDM4EALDH1A1LMNA
SCHEMBL29406990 0.93 OPRM1 (0.36) OPRM1NT5EKDM4EALDH1A1LMNA
SCHEMBL18526374 0.93 OPRM1 (0.36) OPRM1NT5EKDM4EALDH1A1LMNA
SCHEMBL19956800 0.90 NT5E (0.36) OPRM1NT5EKDM4EALDH1A1LMNA
SCHEMBL23029172 0.90 OPRM1 (0.35) OPRM1NT5EKDM4EALDH1A1LMNA
SCHEMBL24942970 0.90 NT5E (0.35) OPRM1NT5EKCNH2
SCHEMBL30112665 0.90 NT5E (0.35) OPRM1NT5EKCNH2
SCHEMBL29720293 0.89 NT5E (0.35) OPRM1NT5EKDM4EALDH1A1LMNA
SCHEMBL18526368 0.89 NT5E (0.35) OPRM1NT5EKDM4EALDH1A1LMNA
SCHEMBL24942980 0.88 NT5E (0.39) OPRM1NT5EALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230038702-A1 BRIGHT TARGETABLE RED CA2+ INDICATORS HOWARD HUGHES MEDICAL INSTITUTE 2023-02-09 — — US disclosed
US-20210054001-A1 BRIGHT TARGETABLE RED CA2+ INDICATORS HOWARD HUGHES MEDICAL INSTITUTE 2021-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230038702-A1 BRIGHT TARGETABLE RED CA2+ INDICATORS ATP2A2, ATP2A3, CACNB2 OPRM1 1011/4885NT5E 1820/4885KDM4E 4621/4885
US-20210054001-A1 BRIGHT TARGETABLE RED CA2+ INDICATORS ATP2A2, ATP2A3, CACNB2 OPRM1 1011/4885NT5E 1820/4885KDM4E 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback